Institutional Ownership
Macrogenics Inc
CUSIP 556099109COMMGNXQ1 2026
13D / 13G Filings
62
Schedule 13D/13G on record
Beneficial Filers
23
Distinct reporting persons
Largest Stake
16.0%
Max % of class reported
Institutional Holders
104
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
62 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 10.0% | 6.32M | SEC |
| 2 | Feb 13, 2026 | Frazier Life Sciences Public Fund, L.P. | 13G/A | — | — | SEC |
| 3 | Jan 6, 2026 | Bellevue Group AG | 13G/A | — | — | SEC |
| 4 | Nov 12, 2025 | Wasatch Advisors LP | 13G/A | 3.1% | 1.95M | SEC |
| 5 | Aug 14, 2025 | Frazier Life Sciences Public Fund, L.P. | 13G/A | 2.5% | 1.55M | SEC |
| 6 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 2.9% | 1.81M | SEC |
| 7 | Jul 7, 2025 | Bellevue Group AG | 13G | 15.7% | 9.93M | SEC |
| 8 | Jun 13, 2025 | Bb Biotech AG | 13G/A | — | — | SEC |
| 9 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 10.0% | 6.30M | SEC |
| 10 | Apr 17, 2025 | Millennium Management LLC | 13G/A | 11.0% | 1.72M | SEC |
52 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Macrogenics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 6.01M | $17.37M |
| 2 | Renaissance Technologies LLC | 2.96M | $8.56M |
| 3 | Millennium Management LLC | 2.79M | $8.08M |
| 4 | Two Sigma Investments, LP | 2.53M | $7.31M |
| 5 | Bank Of America Corp /De/ | 2.40M | $6.94M |
| 6 | Marshall Wace, LLP | 2.03M | $5.85M |
| 7 | Ra Capital Management, L.P. | 1.86M | $5.39M |
| 8 | Wasatch Advisors LP | 1.56M | $4.51M |
| 9 | Blackrock, Inc. | 1.16M | $3.36M |
| 10 | D. E. Shaw & Co., Inc. | 1.06M | $3.06M |